Impact of immune checkpoint inhibitors in cancer immunotherapy
Journal of Cancer Immunology & Therapy (https://www.alliedacademies.org/journal-cancer-immunology-therapy/)
Journal of Cancer Immunology & Therapy is a peer-reviewed, open access journal that reflects articles on all types of tumor immunology. The journal serves as a forum for new concepts and advances in basic Cancer Discovery, Breast Cancer, Cancer Biology, Cancer Treatment, Cancer Management and Research, Integrative Cancer Therapies, Clinical cancer immunology and therapy.
The journal welcomes submissions from all related fields to the Cancer Immunology & Therapy which utilises the immune system as a treatment for cancer. Cancer immunology is an interdisciplinary branch of biology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well-known application is cancer immunotherapy.
The open access journal is published by OMICS International. OMICS International is a leading Open Access publisher that publishes more than 700 leading-edge peer reviewed Open Access Journals and organizes over 1000 International Conferences globally with the support of nearly 1000 International Societies. OMICS International journals cater to over 10 million readers with the support of 50000 eminent personalities as editorial board members.
Prospective academicians and scientists are encouraged to utilize this opportunity to get their contents reviewed, processed and published at relatively faster pace and at low expenditure. In addition to this the authors who publish with us during the year-long celebrations will also be eligible for academic awards recommended by the editorial panel.
You may submit manuscripts as an email attachment to the e-mail id firstname.lastname@example.org
Journal of Cancer Immunology and Therapy
Whats App: +1-97-333-4405